70 related articles for article (PubMed ID: 21461372)
1. Modulation of cytokine and cytokine receptor/antagonist by treatment with doxycycline and tetracycline in patients with dengue fever.
Castro JE; Vado-Solis I; Perez-Osorio C; Fredeking TM
Clin Dev Immunol; 2011; 2011():370872. PubMed ID: 21461372
[TBL] [Abstract][Full Text] [Related]
2. Cytokine profiles in dengue fever and dengue hemorrhagic fever: A study from Indonesia.
Masyeni S; Wardhana IMW; Nainu F
Narra J; 2024 Apr; 4(1):e309. PubMed ID: 38798833
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum PAR-1 levels as an emerging biomarker of inflammation to predict the dengue infection severity.
Sibia RS; Sood A; Subedi A; Sharma A; Mittal A; Singh G; Singh TG; Jaura RS; Goyal S
J Med Virol; 2023 Jan; 95(1):e28152. PubMed ID: 36109338
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of biomarkers for severe dengue infections.
Soo KM; Khalid B; Ching SM; Tham CL; Basir R; Chee HY
PeerJ; 2017; 5():e3589. PubMed ID: 28929009
[TBL] [Abstract][Full Text] [Related]
5. IL-6 Levels in Prediction of Severity of Dengue Fever.
Vachher H; Metgud T; Srikanth B
Indian J Pediatr; 2023 May; 90(5):518. PubMed ID: 36848012
[No Abstract] [Full Text] [Related]
6. Dengue Patients Treated with Doxycycline Showed Lower Mortality Associated to a Reduction in IL-6 and TNF Levels.
Fredeking TM; Zavala-Castro JE; González-Martínez P; Moguel-Rodríguez W; Sanchez EC; Foster MJ; Diaz-Quijano FA
Recent Pat Antiinfect Drug Discov; 2015; 10(1):51-8. PubMed ID: 25858261
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of doxycycline against dengue virus replication in vitro.
Rothan HA; Mohamed Z; Paydar M; Rahman NA; Yusof R
Arch Virol; 2014 Apr; 159(4):711-8. PubMed ID: 24142271
[TBL] [Abstract][Full Text] [Related]
8. Dental disease and risk of coronary heart disease and mortality.
DeStefano F; Anda RF; Kahn HS; Williamson DF; Russell CM
BMJ; 1993 Mar; 306(6879):688-91. PubMed ID: 8471920
[TBL] [Abstract][Full Text] [Related]
9. Study the antiviral activity of some derivatives of tetracycline and non-steroid anti inflammatory drugs towards dengue virus.
Rothan HA; Buckle MJ; Ammar YA; Mohammadjavad P; Shatrah O; Noorsaadah AR; Rohana Y
Trop Biomed; 2013 Dec; 30(4):681-90. PubMed ID: 24522138
[TBL] [Abstract][Full Text] [Related]
10. Combined therapy with ivermectin and doxycycline can effectively alleviate the cytokine storm of COVID-19 infection amid vaccination drive: A narrative review.
Sharma SK; Bhatt P; Asdaq SMB; Alshammari MK; Alanazi A; Alrasheedi NS; Alrashdi BA; Alyami SS; Alhazmi BH; Alam P; Sharma P; Tomar R; Arora MK; Imran M
J Infect Public Health; 2022 May; 15(5):566-572. PubMed ID: 35462191
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulation by Tetracyclines in the Critically Ill: An Emerging Treatment Option?
Sauer A; Putensen C; Bode C
Crit Care; 2022 Mar; 26(1):74. PubMed ID: 35337355
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological basis for the potential role of Azithromycin and Doxycycline in management of COVID-19.
Ali AS; ASattar MA; Karim S; Kutbi D; Aljohani H; Bakhshwin D; Alsieni M; Alkreathy HM
Arab J Chem; 2021 Mar; 14(3):102983. PubMed ID: 34909062
[TBL] [Abstract][Full Text] [Related]
13. Chitosan/PVA/Doxycycline Film and Nanofiber Accelerate Diabetic Wound Healing in a Rat Model.
Hedayatyanfard K; Bagheri Khoulenjani S; Abdollahifar MA; Amani D; Habibi B; Zare F; Asadirad A; Pouriran R; Ziai SA
Iran J Pharm Res; 2020; 19(4):225-239. PubMed ID: 33841538
[TBL] [Abstract][Full Text] [Related]
14.
Dunowska M; Ghosh S
Pathogens; 2021 Mar; 10(3):. PubMed ID: 33799985
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of Autoimmune Diseases with Nonantibiotic Properties of Tetracyclines.
Park CS; Kim SH; Lee CK
Immune Netw; 2020 Dec; 20(6):e47. PubMed ID: 33425432
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2.
Gendrot M; Andreani J; Jardot P; Hutter S; Delandre O; Boxberger M; Mosnier J; Le Bideau M; Duflot I; Fonta I; Rolland C; Bogreau H; La Scola B; Pradines B
Molecules; 2020 Oct; 25(21):. PubMed ID: 33142770
[TBL] [Abstract][Full Text] [Related]
17. Doxycycline as a potential partner of COVID-19 therapies.
Malek AE; Granwehr BP; Kontoyiannis DP
IDCases; 2020; 21():e00864. PubMed ID: 32566483
[TBL] [Abstract][Full Text] [Related]
18. Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators.
Schmidt KE; Kuepper JM; Schumak B; Alferink J; Hofmann A; Howland SW; Rénia L; Limmer A; Specht S; Hoerauf A
PLoS One; 2018; 13(2):e0192717. PubMed ID: 29438386
[TBL] [Abstract][Full Text] [Related]
19. Tetracyclines downregulate the production of LPS-induced cytokines and chemokines in THP-1 cells via ERK, p38, and nuclear factor-κB signaling pathways.
Sun J; Shigemi H; Tanaka Y; Yamauchi T; Ueda T; Iwasaki H
Biochem Biophys Rep; 2015 Dec; 4():397-404. PubMed ID: 29124230
[TBL] [Abstract][Full Text] [Related]
20. Case Management of Dengue: Lessons Learned.
Kalayanarooj S; Rothman AL; Srikiatkhachorn A
J Infect Dis; 2017 Mar; 215(suppl_2):S79-S88. PubMed ID: 28403440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
